About Index Trending news
Analyze
Pricing
Promethera Biosciences

Promethera Biosciences

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

Prosensa Prosensa TapImmune TapImmune FLX Bio, Inc. FLX Bio, Inc. Merus Merus Tioma Therapeutics Tioma Therapeutics Proclara Biosciences Proclara Biosciences Therachon AG Therachon AG ApcinteX Limited ApcinteX Limited Sphere Fluidics Ltd Sphere Fluidics Ltd MetaStat Inc. MetaStat Inc.

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview
Add info
Add round
27 Oct 2016
€10,000,000
Venture capital (Series C)
Mitsui & Co. Global Investment, Mitsubishi UFJ Capital, Vesalius Biocapital Partners, +4

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

businesswire
25 Nov 2014
$31,444,456
Venture capital (Series C)
28 Mar 2012
$31,475,320
Venture capital (Series B)
Mitsui & Co. Global Investment, Boehringer Ingelheim Venture Fund, Shire
02 Feb 2010
$7,300,000
Venture capital (Series A)
Life Sciences Partners, Vesalius Biocapital Partners, Société Régionale d'Investissement de Wallonie